AASLD member registration and housing is now open at the DDW Website. Register on or before April 2, 2010, and registration is only $95. After April 2, 2010, registration fees will be $195.
DDW General Information and Registration
Digestive Disease Week ® is the largest gathering of clinicians, educators and researchers focusing on the digestive system. As a sponsoring society, AASLD’s successful liver-specific sessions will include State-of-the-Art Lectures, Clinical Symposia, Plenary Sessions, Research and Topic Fora and Poster Presentations. AASLD continues to bring attention to important subjects where controversy and/or information can be presented for practicing clinicians and academicians.
DDW Diversity Reception, Monday, May 3, 2010
Goals and Objectives
• Provide a forum for exchange of new scientific and clinical information relevant to the study of liver disease
• Create an arena for the interchange of opinions regarding the care and management of all types of liver disease
• Assess new diagnostic or therapeutic techniques related to liver disease
Online registration for DDW is now available for members of AASLD, AGA, ASGE and SSAT. Registration opens Jan. 13 for nonmembers. Please follow the link above to register for DDW.
Guide to Liver Sessions at DDW
Click the link above to view the full AASLD schedule at Digestive Disease Week®.
AASLD programs will include:
Difficult Management Problems in Viral Hepatitis Clinical Symposium
• Discuss management options in prior non-responders to pegylated interferon and ribavirin.
• Discuss management of viral hepatitis in those with compensated and
decompensated cirrhosis including surveillance for hepatocellular carcinoma, esophageal varices, and timing of referral for liver transplantation.
• Discuss management of chronic hepatitis B in those with mild disease who do not meet current guideline for initiating anti-HBV therapy.
NASH Novel Approaches Clinical Symposium
• Describe the strengths and weaknesses of currently available alternatives to liver biopsy for the evaluation of patients suspected of having fatty liver disease.
• Describe the rationale, risks and benefits of selecting various insulin sensitizing drugs for the treatment of NASH.
• Describe the importance of screening patients with NASH for the associated co-morbidities and understanding the potential role of oxidant stress in the insulin resistance and NASH.
Non-invasive Serum Markers: Translation into Clinical Practice Clinical Symposium
• Understand the advantages and potential limitations of liver biopsy in the evaluation of patients with suspected liver disease.
• Become familiar with currently available noninvasive serum and imaging techniques for detecting hepatic fibrosis.
• Understand the potential strategies and impacts for using noninvasive tests in the management of patients with know or suspected liver disease.
Practitioners Corner: What's New and Hot in Clinical Hepatology
• Describe alternatives to liver biopsy in evaluating liver disease.
• Identify the most effective therapeutic strategy for a given hepatocelluar cancer patient
• Discuss how to optimally manage coagulation in patients with liver disease
• Discuss the indications and contraindications to TIPS in refractory ascites and hepatic hydrothorax
Recent Advances in Pediatric Viral Hepatitis Clinical Symposium
• Screening, monitoring and management of viral hepatitis using appropriate testing.
• Understand the various treatment options available and their effectiveness.
• Select patients who need therapy and understand monitoring protocols of the patients before, during and after therapy.
• Understand how children differ from adults with the same diseases.
Renal Failure in the Patient with Cirrhosis Clinical Symposium
• Diagnose the cause of renal failure in the patient with cirrhosis
• Understand why patients with cirrhosis develop hepatorenal syndrome
• Understand how newer agents improve renal function in cirrhosis
The Liver Patient in the ICU Clinical Symposium
• Function as an integral member of a multidisciplinary team providing specialized management to critically ill patients with liver disease.
• Describe the key pathophysiologic changes in critically ill liver patients with regard to neurologic, cardiac and renal function and infectious risks in ICU patients with liver disease
• Recognize the multiple organ dysfunction that occurs in advanced liver disease, and understand the emerging concepts underlying the entity of acute on chronic liver failure (ACLF)
• Select patients appropriate for liver transplantation and liver assist devices, such that outcomes may be optimized
Advances in Hepatology: The Year in Review
• To improve patient care by increasing learner competence in diagnosing and treating patients with acute and chronic liver disease
• To broaden the field of research for investigators studying liver biology and disease
State-of-the-Art Lectures
The Therapy of Hepatitis B Virus Infection: Current and Future Therapies
• Improve patient outcomes in terms of drug resistance and disease progression
The Treatment of Hepatitis C Virus Infection: Past, Present and Future
• Identify host and viral factors associated with treatment response
• Incorporate response-guided therapy into treatment algorithms
• Evaluate the impact and management of anemia during interferon-based therapy
• Explore new treatment options with STAT-C agents and how they will impact patient responses
Acute on Chronic Liver Failure
• Identify patients with cirrhosis at risk of dying
• Define precipitating events
• Propose treatment options
Minimal Encephalopathy: Why You Should Care About It
• Understand the importance and prevalence of minimal hepatic encephalopathy
• Understand the methods for the diagnosis of minimal hepatic encephalopathy
• Understand the treatment strategies for minimal hepatic encephalopathy
Management Strategies for Hepatocellular Cancer
• Understand treatment options for HCC
• Appreciate staging systems and algorithms for HCC
• Distinguish appropriate candidates for possibly curative therapy of HCC
